Skip to content
RDL Network logo
Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 Study — Arnaud Jaccard (2024) | RDL Network